ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Commercialized
Register Number
82591
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Nov 12, 2017
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number82591
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (2)
ABACAVIR CLORHIDRATOActive
Quantity: 676.401 mg
Name: ABACAVIR CLORHIDRATO
LAMIVUDINAActive
Quantity: 300 mg
Name: LAMIVUDINA
ATC CLASSIFICATION (3)
J05A
J05AR
J05AR02